TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2019

SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).

Charu Aggarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.